Skip to Main Content

Paper Details

Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
Oncotarget
21
2015
4E-BP1, 70S6K, AKT, ATC, ATC cell lines, Anaplastic thyroid cancer, Torin2, anaplastic thyroid cancer, caspase, claspin, human, mTOR, malignancies, metastatic ATC, mouse, survivin, tumor
Author NameAffiliation
Samira M SadowskiNational Cancer Institute, National Institutes of Health
Samira M SadowskiNational Cancer Institute, National Institutes of Health
Myriem BoufraqechNational Cancer Institute, National Institutes of Health
Myriem BoufraqechNational Cancer Institute, National Institutes of Health
Lisa ZhangNational Cancer Institute, National Institutes of Health
Lisa ZhangNational Cancer Institute, National Institutes of Health
Amit MehtaGeisel School of Medicine at Dartmouth
Amit MehtaGeisel School of Medicine at Dartmouth
Yaqin ZhangNational Center for Advancing Translational Sciences, National Institutes of Health
Yaqin ZhangNational Center for Advancing Translational Sciences, National Institutes of Health
Zhuyin LiNational Center for Advancing Translational Sciences, National Institutes of Health
Zhuyin LiNational Center for Advancing Translational Sciences, National Institutes of Health
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Electron KebebewNational Cancer Institute, National Institutes of Health
Electron KebebewNational Cancer Institute, National Institutes of Health
  • 1 - 16

Datasets